- FDA sees high vacancy rates for drug manufacturer inspectors🔍
- FDA still lacks enough inspectors🔍
- FDA Should Implement Strategies to Retain Its Inspection Workforce🔍
- In addressing inspection shortfall🔍
- FDA Global Drug Inspections🔍
- FDA has massive backlog of factory inspections as staffers leave for ...🔍
- Serious concerns raised over FDA's capacity to inspect overseas ...🔍
- Testimony About FDA's Foreign Drug Establishment Inspection ...🔍
FDA sees high vacancy rates for drug manufacturer inspectors
FDA sees high vacancy rates for drug manufacturer inspectors
The Food and Drug Administration (FDA) is having trouble retaining employees who inspect drug manufacturers. The vacancy rate for these FDA ...
FDA still lacks enough inspectors, GAO says - STAT News
FDA is still struggling with a lack of inspectors, but doesn't have a plan, watchdog finds · Between November 2021 and June, the vacancy rate ...
FDA Should Implement Strategies to Retain Its Inspection Workforce
Since resuming inspections, FDA has struggled to retain staff. From Nov. 2021 to June 2024, the vacancy rate among investigators who inspect ...
FDA Should Implement Strategies to Retain Its Inspection Workforce
However, since then, investigator attrition has generally outpaced hiring and has resulted in a large number of relatively inexperienced ...
In addressing inspection shortfall, FDA says it's gaining more ...
Data compiled from the FDA's inspection dashboard and analyzed by the AP show that the regulator conducted at least 4,200 drug plant inspections ...
FDA Global Drug Inspections: Surveillance Of Manufacturing ...
By 2022, numbers of inspections remained well below prepandemic levels, with a 79 percent decrease in foreign inspections and a 35 percent decline in domestic ...
FDA has massive backlog of factory inspections as staffers leave for ...
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected during disruptions ...
Serious concerns raised over FDA's capacity to inspect overseas ...
The FDA is tasked with regularly inspecting drug manufacturing ... high vacancy rate among the agency's inspector corps. According to ...
Serious concerns raised over FDA's capacity to inspect overseas ...
The FDA is tasked with regularly inspecting drug manufacturing ... high vacancy rate among the agency's inspector corps. Advertisement ...
Testimony About FDA's Foreign Drug Establishment Inspection ...
By the end of FY2019, 495 or 51% of these had been inspected, 359 or 37% had been removed from CDER's list for a variety of reasons and were no ...
FDA Global Drug Inspections - Health Affairs
and Drug Administration (FDA) halted inspections of most overseas drug manufacturing establishments. Looking at data from the period 2012–22 ...
FDA's Foreign Inspections of Drug Manufacturers Have ... - YouTube
The Food and Drug Administration (FDA) inspects drug manufacturers here and overseas to ensure the safety and quality of drug sold in the ...
FDA's Foreign Drug Manufacturing Inspection Process | C-SPAN.org
The Senate Finance Committee held a hearing with drug manufacturers and Food and Drug Administration officials on the agency's foreign drug ...
FDA inspection data on nearly 1000 overseas drug firms is missing
Also troubling to the GAO is the persistently high vacancy rates at the FDA's foreign offices. Its report concluded that 46% of positions in ...
Oversight of FDA's Foreign Inspection Program - Congress.gov
FDA conducts three types of inspections of drug ... effectiveness of its foreign offices, which still suffered from high vacancy rates.
FDA inspection backlog overseas threatens new drug approvals
Roughly 2,000 pharma manufacturers haven't been inspected by the FDA since before the pandemic, according to a recent analysis from the ...
covid–19 and beyond: oversight of the fda's foreign drug ... - GovInfo
inspection capability. In 2010 and 2016, we found that these offices faced persistently high vacancy rates, raising questions about their.
See IOM 5.1.1 and 5.11.4.3.3. For multiple occupancy inspections in drug establishments, refer to IOM 5.1.1.11. Inspections of multiple firms, which.
Today's News and Commentary — HealthcareInsights.MD
Inspections help ensure that the drugs Americans rely on are safe. Since resuming inspections, FDA has struggled to retain staff. From Nov. 2021 ...
Nearly 2,000 drug manufacturing plants are overdue ... - Baltimore Sun
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds · Featured Local Savings · Most Popular.